|Bid||0.21 x 0|
|Ask||0.23 x 0|
|Day's Range||0.2100 - 0.2300|
|52 Week Range||0.0300 - 0.3300|
|Beta (3Y Monthly)||-2.65|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Bard Ventures Ltd. (the “Company” or “Bard”) is pleased to announce that it will hold its annual and special meeting of shareholders (the “AGM”) at the offices of the Company located at Suite 810 – 789 West Pender Street, Vancouver, BC V6C 1H2 on October 31, 2018 at 9:00 am PST and has nominated Mr. Ning Wu for position on the Bard’s board of directors. Mr. Ning Wu serves as General Manager and is the Founder of Shanghai Shouye Biotech Co. Ltd. since 2011. Through his experiences, Mr. Wu acquired his knowledge in medicine by independent study and has developed 6 patents of various Chinese herbal medication, equipment and processes.
Eugene Beukman is the CEO of Bard Ventures Ltd (TSXV:CBS), which has recently grown to a market capitalization of CA$1.51M. Recognizing whether CEO incentives are aligned with shareholders is aRead More...